Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Hepatitis A Virus Cellular Receptor 2 market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Hepatitis A Virus Cellular Receptor 2market, defines the market attractiveness level of Hepatitis A Virus Cellular Receptor 2 market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Hepatitis A Virus Cellular Receptor 2 industry, describes the types of Hepatitis A Virus Cellular Receptor 2 market, the applications of major players and the market size, and deeply analyzes the current situation of the global Hepatitis A Virus Cellular Receptor 2 market and the development prospects and opportunities of Hepatitis A Virus Cellular Receptor 2 industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Hepatitis A Virus Cellular Receptor 2 market in Chapter 13.
By Player:
Enumeral Biomedical Holdings Inc
Jounce Therapeutics Inc
Trellis Bioscience Inc
Interprotein Corp
Incyte Corp
Aurigene Discovery Technologies Ltd
Eli Lilly and Co
Sutro Biopharma Inc
Tesaro Inc
BeiGene Ltd
Sorrento Therapeutics Inc
Merus NV
Novartis AG
By Type:
IMM-1802
LY-3321367
MCLA-134
CA-170
CA-327
ENUM-005
Others
By End-User:
Colon Cancer
Myelodysplastic
Non-Small Cell Lung Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Hepatitis A Virus Cellular Receptor 2 Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Hepatitis A Virus Cellular Receptor 2 Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Hepatitis A Virus Cellular Receptor 2 Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Hepatitis A Virus Cellular Receptor 2 Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Hepatitis A Virus Cellular Receptor 2 Market Analysis and Outlook to 2022
-
7.1 Global Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.2 United States Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.3 Europe Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.4 China Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.5 Japan Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.6 India Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
-
7.7 South Korea Hepatitis A Virus Cellular Receptor 2 Consumption (2017-2022)
8 Region and Country-wise Hepatitis A Virus Cellular Receptor 2 Market Analysis and Outlook to 2028
-
8.1 Global Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.2 United States Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.3 Europe Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.4 China Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.5 Japan Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.6 India Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
-
8.7 South Korea Hepatitis A Virus Cellular Receptor 2 Consumption Forecast (2022-2028)
9 Global Hepatitis A Virus Cellular Receptor 2 Market Outlook by Types and Applications to 2022
-
9.1 Global Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global IMM-1802 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global LY-3321367 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global MCLA-134 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global CA-170 Consumption and Growth Rate (2017-2022)
-
9.1.5 Global CA-327 Consumption and Growth Rate (2017-2022)
-
9.1.6 Global ENUM-005 Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Myelodysplastic Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Others Consumption and Growth Rate (2017-2022)
10 Global Hepatitis A Virus Cellular Receptor 2 Market Outlook by Types and Applications to 2028
-
10.1 Global Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global IMM-1802 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global LY-3321367 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global MCLA-134 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global CA-170 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global CA-327 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global ENUM-005 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Myelodysplastic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Hepatitis A Virus Cellular Receptor 2 Import and Export Analysis (Top 5 Countries)
-
11.1 Global Hepatitis A Virus Cellular Receptor 2 Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Hepatitis A Virus Cellular Receptor 2 Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Hepatitis A Virus Cellular Receptor 2 Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Hepatitis A Virus Cellular Receptor 2 Market Competitive Analysis
-
14.1 Enumeral Biomedical Holdings Inc
-
14.1.1 Enumeral Biomedical Holdings Inc Company Details
-
14.1.2 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.2 Jounce Therapeutics Inc
-
14.2.1 Jounce Therapeutics Inc Company Details
-
14.2.2 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.3 Trellis Bioscience Inc
-
14.3.1 Trellis Bioscience Inc Company Details
-
14.3.2 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.4 Interprotein Corp
-
14.4.1 Interprotein Corp Company Details
-
14.4.2 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.5 Incyte Corp
-
14.5.1 Incyte Corp Company Details
-
14.5.2 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.6 Aurigene Discovery Technologies Ltd
-
14.6.1 Aurigene Discovery Technologies Ltd Company Details
-
14.6.2 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.7 Eli Lilly and Co
-
14.7.1 Eli Lilly and Co Company Details
-
14.7.2 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.8 Sutro Biopharma Inc
-
14.8.1 Sutro Biopharma Inc Company Details
-
14.8.2 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.9 Tesaro Inc
-
14.9.1 Tesaro Inc Company Details
-
14.9.2 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.10 BeiGene Ltd
-
14.10.1 BeiGene Ltd Company Details
-
14.10.2 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.11 Sorrento Therapeutics Inc
-
14.11.1 Sorrento Therapeutics Inc Company Details
-
14.11.2 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.12 Merus NV
-
14.12.1 Merus NV Company Details
-
14.12.2 Merus NV Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Merus NV Hepatitis A Virus Cellular Receptor 2 Product and Service
-
14.13 Novartis AG
-
14.13.1 Novartis AG Company Details
-
14.13.2 Novartis AG Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Novartis AG Hepatitis A Virus Cellular Receptor 2 Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Hepatitis A Virus Cellular Receptor 2
-
Figure Hepatitis A Virus Cellular Receptor 2 Picture
-
Table Global Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis A Virus Cellular Receptor 2 Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Hepatitis A Virus Cellular Receptor 2 Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Hepatitis A Virus Cellular Receptor 2 Consumption by Country (2017-2022)
-
Figure United States Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Table Europe Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Figure China Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Figure Japan Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Figure India Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Figure South Korea Hepatitis A Virus Cellular Receptor 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis A Virus Cellular Receptor 2 Consumption Forecast by Country (2022-2028)
-
Figure United States Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Hepatitis A Virus Cellular Receptor 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global IMM-1802 Consumption and Growth Rate (2017-2022)
-
Figure Global LY-3321367 Consumption and Growth Rate (2017-2022)
-
Figure Global MCLA-134 Consumption and Growth Rate (2017-2022)
-
Figure Global CA-170 Consumption and Growth Rate (2017-2022)
-
Figure Global CA-327 Consumption and Growth Rate (2017-2022)
-
Figure Global ENUM-005 Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Myelodysplastic Consumption and Growth Rate (2017-2022)
-
Figure Global Non-Small Cell Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global IMM-1802 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global LY-3321367 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global MCLA-134 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CA-170 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CA-327 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global ENUM-005 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Myelodysplastic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Non-Small Cell Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Hepatitis A Virus Cellular Receptor 2 Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Hepatitis A Virus Cellular Receptor 2 Export by Region (Top 5 Countries) (2017-2028)
-
Table Enumeral Biomedical Holdings Inc (Foundation Year, Company Profile and etc.)
-
Table Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enumeral Biomedical Holdings Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Jounce Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jounce Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Trellis Bioscience Inc (Foundation Year, Company Profile and etc.)
-
Table Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Trellis Bioscience Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Interprotein Corp (Foundation Year, Company Profile and etc.)
-
Table Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Interprotein Corp Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Incyte Corp (Foundation Year, Company Profile and etc.)
-
Table Incyte Corp Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Incyte Corp Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Aurigene Discovery Technologies Ltd (Foundation Year, Company Profile and etc.)
-
Table Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aurigene Discovery Technologies Ltd Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Eli Lilly and Co (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Co Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Sutro Biopharma Inc (Foundation Year, Company Profile and etc.)
-
Table Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sutro Biopharma Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Tesaro Inc (Foundation Year, Company Profile and etc.)
-
Table Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Tesaro Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table BeiGene Ltd (Foundation Year, Company Profile and etc.)
-
Table BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table BeiGene Ltd Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Sorrento Therapeutics Inc (Foundation Year, Company Profile and etc.)
-
Table Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sorrento Therapeutics Inc Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Merus NV (Foundation Year, Company Profile and etc.)
-
Table Merus NV Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merus NV Hepatitis A Virus Cellular Receptor 2 Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Hepatitis A Virus Cellular Receptor 2 Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Hepatitis A Virus Cellular Receptor 2 Product and Service
-
